Mark Harrington of TAG and Dr. Demetre Daskalakis of NYC Health Dept. Respond to NY Times Opinion Piece About PrEP
Read Mark and Demetre's response to The New York Times June 26 opinion piece, "The End of Safe Gay Sex?"
Read Mark and Demetre's response to The New York Times June 26 opinion piece, "The End of Safe Gay Sex?"
Ending the Epidemic: Building Effective Collaboration between Community Advocates and Health Departments, presented by Treatment Action Group and Housing Works, May 31, 2018 Since 2014, community-led Ending the Epidemic (EtE) initiatives have advanced across the nation, setting ambitious targets to…
In 2014, Governor Andrew Cuomo backed a community advocated plan to aggressively scale up testing, linkage to treatment, and PrEP access in order to dramatically reduce new infections below epidemic levels by the year 2020. The good news is that…
Bend the Curves: Incremental change—activism that successfully defends or advances critical research or policy—can sometimes feel inconsequential, particularly when it is hard won, resource intensive, and intangible.
By Suraj Madoori During Trump’s first-ever State of the Union address on January 30, activists observed a dearth of clear priorities to eliminate HIV/AIDS, tuberculosis (TB), and hepatitis C virus (HCV) in the U.S. Science and longstanding bipartisan interest in…
By Jeremiah Johnson The December 2017 release of the New York State (NYS) 2016 HIV/AIDS surveillance data shows that the efforts to End the Epidemic (EtE) in New York are having an impact. In 2014, Governor Andrew Cuomo backed a…
Slide decks for the Updated Training Manual for Treatment Advocates: Hepatitis C Virus & Coinfection with HIV.
Introduction For many HIV-positive people—particularly those who initiate treatment soon after infection—combination antiretroviral therapy (ART) is associated with robust improvements in CD4+ T cell counts, enhanced immune function, and a life expectancy comparable to that of similar HIV-negative individuals. But a…
Pregnant women have frequently been excluded from or de-prioritized in clinical research initiatives due to a multitude of factors, such as the complex physiology of pregnant women, the risk studies may pose to the fetus, and the classification of pregnant…
The purpose of this Training Manual is to provide information for you and your community. This information can be used to advocate for access to prevention and diagnosis of, and care and treatment for, hepatitis C virus (HCV). The manual is written by and for people who are not medical specialists. We’re treatment activists who learned about HCV because it was a problem for people in our communities.